Potential of the tumor‑derived extracellular vesicles carrying the miR‑125b‑5p target TNFAIP3 in reducing the sensitivity of diffuse large B cell lymphoma to rituximab-Reference-Cited by-同舟云学术

Potential of the tumor‑derived extracellular vesicles carrying the miR‑125b‑5p target TNFAIP3 in reducing the sensitivity of diffuse large B cell lymphoma to rituximab

Published:2021-04-21 Issue:6 Volume:58 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Zhang Li¹,Zhou Shixia²,Zhou Tiejun³,Li Xiaoming²,Tang Junling²

Affiliation:

1. Department of Oral and Maxillofacial Surgery, The Affiliated Stomatology Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China

2. Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China

3. Department of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular RNA in oncogenesis, metastasis and drug resistance;RNA Biology;2024-08-06

2. LCN2: Versatile players in breast cancer;Biomedicine & Pharmacotherapy;2024-02

3. TNFAIP3 Overexpression Inhibits Diffuse Large B-Cell Lymphoma Progression by Promoting Autophagy through TLR4/MyD88/NF-κB Signaling Pathway;Discovery Medicine;2024

4. The Role of MicroRNAs in Mature B-Cell Neoplasias Drug Resistance;Comprehensive Hematology and Stem Cell Research;2024

5. Research advances in exosomal microRNAs associated with drug resistance in diffuse large B-cell lymphoma;Asian Journal of Surgery;2023-11